Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
Young, Richard J., Waldeck, Kelly, Martin, Claire, Foo, Jung H., Cameron, Donald P., Kirby, Laura, Do, Hongdo, Mitchell, Catherine, Cullinane, Carleen, Liu, Wendy, Fox, Stephen B., Dutton-Regester, Ken, Hayward, Nicholas K., Jene, Nicholas, Dobrovic, Alexander, Pearson, Richard B., Christensen, James G., Randolph, Sophia, McArthur, Grant A., Sheppard, Karen E.
Published in Pigment cell and melanoma research (01.07.2014)
Published in Pigment cell and melanoma research (01.07.2014)
Get full text
Journal Article
Abstract P5-17-05: It's as simple as ABC: Can we improve the provision of coordinated medical and supportive care to patients with advanced breast cancer?
Greenberg, Sally, Pitcher, Meron, Mann, Bruce, Hendry, Kathleen, Shanahan, Kerry, Fisher, Melanie K, Foo, Jung H
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
Loss of CDKN 2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK 4/6 inhibitor PD 0332991 in melanoma cell lines
Young, Richard J., Waldeck, Kelly, Martin, Claire, Foo, Jung H., Cameron, Donald P., Kirby, Laura, Do, Hongdo, Mitchell, Catherine, Cullinane, Carleen, Liu, Wendy, Fox, Stephen B., Dutton‐Regester, Ken, Hayward, Nicholas K., Jene, Nicholas, Dobrovic, Alexander, Pearson, Richard B., Christensen, James G., Randolph, Sophia, McArthur, Grant A., Sheppard, Karen E.
Published in Pigment cell and melanoma research (01.07.2014)
Published in Pigment cell and melanoma research (01.07.2014)
Get full text
Journal Article